ArticleBritish journal of cancer2011

Discontinuation of proton pump inhibitors during assessment of chromogranin A levels in patients with neuroendocrine tumours.

C M Korse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.